Portfolio Companies
The Global Cleantech 100 Gala honored and celebrated the achievements of the 2013 Global Cleantech 100 companies, the 100 top innovators in cleantech today.
Two of Claremont Creek Ventures portfolio companies, Alphabet Energy and Clean Power Finance were named to the list to the top 100 Global Cleantech companies.
Read More
Congratulations to our portfolio company NuMedii for a publication today in Cancer Discovery, which discusses the use of its technology by Stanford researchers to identify an antidepressant as a potential treatment for small cell lung cancer. NuMedii is a pioneer in the future of pharmacology. As medicine becomes more personalized, every individual will get a […]
Read MoreCongratulations to our portfolio company Assurex Health which appointed Consumer Products Executive Virginia Coleman Drosos President to Lead the company. We are so excited to have her in this position and wish her all the best.
Read MoreEarlier this week one of our portfolio companies, Genalyte, Inc., announced the release of a groundbreaking diagnostic system for early detection of Type 1 diabetes. This is of special significance to me as the young daughter of a good friend almost died due to undiagnosed Type 1 Diabetes – she was discovered by her parents […]
Read MoreI am thrilled to announce today that Coinstar, now called Outerwall (NASDAQ:OUTR), the publicly held purveyor of 64,000 coin-counting and Redbox movie and video game rental kiosks, has acquired Claremont Creek portfolio company ecoATM for $350 million in cash. What a promising acquisition it is! ecoATM makes automated, self-serve kiosks that quickly evaluate and buy back […]
Read MoreOne of the toughest challenges for a startup is managing through a growth phase while still keeping an eye ahead to a strategy for the next phase. For the past few years I’ve enjoyed enlisting teams of Duke students to get out of the classroom and help company’s in our portfolio with a bit of […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.